Sorry, you need to enable JavaScript to visit this website.
Skip to main content
 

Search

As always, Janssen remains committed to healthcare professionals and patients, as well as to our employees and communities
As always, Janssen remains committed to healthcare professionals and patients, as well as to our employees and communities
COVID-19 Coronavirus Infections

COVID19 Response

 

Lisa Ling speaks with Johnson & Johnson Chief Scientific Officer Dr. Paul Stoffels, and Harvard’s Dan Barouch, M.D., Ph.D. about the latest findings in preclinical trials about an investigational COVID19 vaccine published in Nature and why the results are so encouraging. Each episode streams live on Twitter at @JanssenGlobal as well as our YouTube and LinkedIn channels.

For COVID-19-Related Media Inquiries, click here.